ABOLOGIX is admitted to Fondation Eclosion, the Geneva life sciences incubator

Geneva, Switzerland, September 5, 2018


Abologix has been selected to enter Fondation Eclosion, the Geneva Life Sciences incubator supported by the Republique et canton de Genève. Under the program Abologix will receive invaluable business, scientific and financial support.


“We are honoured and grateful to have been selected to participate in this incubation program. This will allow the company to access critical resources required for its growth. We hope to make a lasting contribution to the growth of the biotechnology ecosystem in the city of Geneva”.

said Ignacio Faus, co-founder and Chairman of the Board of Abologix.

ABOLOGIX awarded a two year Innosuisse Innovation

Geneva, Switzerland, Juy 24, 2020. Abologix has been granted a 2 year Innosuisse Innovation project in collaboration with the University Hospital of Geneva (HUG). The HUG will be the research partner